血清度-剂量关系和调节因子在儿童和青少年治疗弗卢沃胺治疗
Regina Taurines1, Gesa Kunkel1, Stefanie Fekete1
1Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Centre for Mental Health, University Hospital of Wuerzburg, 97080 Wuerzburg, Germany.
Pharmaceutics
|June 27, 2024
概括
这项研究发现,较高的身体质量指数 (BMI) 与患有强迫症 (OCD) 的年轻人中的较低的度有关. 在这些年轻患者中建立了黄素的初步治疗参考范围 (TRR).
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科精神病学 儿科精神病学
- 临床化学 临床化学
背景情况:
- 弗卢沃克萨明是为儿科强迫症 (OCD) 处方的,并非标签用于其他疾病.
- 了解弗洛沃胺剂量,血清度和青少年治疗结果之间的关系至关重要.
研究的目的:
- 在儿科患者中研究黄胺的剂量度关系.
- 为了确定影响fluvoxamine血清度的因素.
- 为患有强迫症的青少年建立初步治疗参考范围 (TRR).
主要方法:
- 分析多中心自然学数据和前性研究数据.
- 评估患者和治疗特征使用标准化措施,如CGI-S和CGI-I.
- 多变量回归分析以确定fluvoxamine血清度的相关值.
主要成果:
- 在每日用量和血清度之间观察到微弱的正相关性.
- 较高的黄素剂量和较低的体重指数 (BMI) 是血清度增加的显著相关物.
- 强迫症青少年的初步TRR估计为55-371 ng/mL.
结论:
- 初步数据表明,青少年患有强迫症的FLUVOXAMINE具有TRR.
- 在这个人群中,较高的BMI与较低的血清度有关.
- 这些发现有助于优化儿科强迫症患者的fluvoxamine治疗.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
120
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
120
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.0K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.0K
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215


